Merck's Player RosterBy Baselinemag | Posted 2004-06-08 Email Print
Re-Thinking HR: What Every CIO Needs to Know About Tomorrow's Workforce REGISTER >
A pair of pharmaceutical outsiders lead Merck's charge
Senior Vice President, Chief Information Officer
Mr. Efficiency? Scalet joined Merck in March 2003 from International Paper, where he had been CIO since 1997. He plans to bring some of the paper industry's tight-fisted ways to a company that has enjoyed seemingly boundless margins. Scalet will need to consolidate and standardize systems as well as promote use of off-the-shelf software packages while finding new ways to support revenue-producing research efforts.
Raymond V. Gilmartin
Chairman, President and Chief Executive Officer
Gilmartin is no stranger to questions about why someone from outside the pharmaceutical industry could be the right person for the job. He was recruited from medical equipment maker Becton, Dickinson and Co. in 1994. Investors put aside those questions in the years when Merck's earning growth averaged 17% annually, but they're calling for his head now that earnings are down 4.5% from 2002 to 2003.
Richard T. Clark
President, Merck Manufacturing Division
Oversees not just manufacturing, but information
servicesand "operational excellence." Ran Merck's Medco pharmacy benefits
management business until it was spun off in 2003. Now, he's Scalet's boss.
Divisional CIO for Research Information Services
Qualters finds ways to use computing and communications to support Merck's search for new drugs. She served as Merck's interim CIO from May 2002 until Scalet arrived in March 2003.
Peter S. Kim
President, Merck Research Laboratories
Kim leads the research organization charged with discovering new medicines. He is also working on compressing the time from when a promising drug is identified to when it enters large
Judy C. Lewent
Chief Financial Officer
Lewent is widely respected for the financial discipline she imposes at Merck, in information technology as well as any other area.
Merck's CIO from October 1991 to January 1999, Popper is considered an expert in how companies govern
operations. At Merck, he established rigorous project-approval and portfolio management processes for technology projects. He now runs his own technology management consulting firm.
Before joining Merck as director of Research Information Services in 1997, Dayem was director of the computing, information and communications division of Los Alamos National Laboratory. He succeeded Popper as CIO in 1999, but left in 2002 to become CIO of pharmaceutical firm Amgen.
Former Divisional CIO, Merck U.S. Human Health
Until retiring last year, Abramson was the divisional CIO for Merck U.S. Human Health, the company's domestic sales and marketing organization. He guided the in-house development of Merck's sales force automation software.
Former Director of Clinical Trial System Standards
The standard-setter. Sromovsky was active in setting eXtensible Markup Language standards for clinical trials as a way of achieving greater standardization within Merck itself.